Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors
S Stavropoulou De Lorenzo, A Andravizou… - Biomedicines, 2024 - mdpi.com
The use of immune checkpoint inhibitors (ICIs) for the treatment of various advanced and
aggressive types of malignancy has significantly increased both survival and long-term …
aggressive types of malignancy has significantly increased both survival and long-term …
Synergistic effects of immune checkpoints and checkpoint inhibitors in inflammatory neuropathies: Implications and mechanisms
A Sarkar, M Nagappa, S Dey, S Mondal… - Journal of the …, 2024 - Wiley Online Library
Immune checkpoint molecules play pivotal roles in the regulation of immune homeostasis.
Disruption of the immune checkpoints causes autoimmune/inflammatory as well as …
Disruption of the immune checkpoints causes autoimmune/inflammatory as well as …
[HTML][HTML] Facial palsy after administration of immune checkpoint inhibitors: case report, literature review and clinical care management
E Mezni, G Corazza, R Mari, S Coze… - Frontiers in …, 2024 - frontiersin.org
Neurological immune-related adverse events (irAEs) due to immune checkpoint inhibitors
(ICI) are rare complications of immunotherapy, particularly dreadful for patients and clinical …
(ICI) are rare complications of immunotherapy, particularly dreadful for patients and clinical …
Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors
S Afzal, Y Li, B Lapin, LH Hua… - Annals of Clinical …, 2024 - Wiley Online Library
This study evaluated disease activity in people with Multiple Sclerosis (PwMS) who received
immune checkpoint inhibitors (ICIs) compared to PwMS not treated with ICIs. There were …
immune checkpoint inhibitors (ICIs) compared to PwMS not treated with ICIs. There were …
[PDF][PDF] Association between response to neoadjuvant chemotherapy and survival outcome after radical surgery in patients with yielding pathological T2≤ and/or N+ …
M Miyake, N Nishimura, N Marugami, T Fujii… - Journal of Clinical and …, 2023 - jctres.com
ABSTRACT Background and Aim: In early 2022, the use of adjuvant nivolumab for patients
with high-risk muscleinvasive urothelial carcinoma (MIUC) was approved in Japan …
with high-risk muscleinvasive urothelial carcinoma (MIUC) was approved in Japan …
[PDF][PDF] ARISTOTLE UNIVERSITY OF THESSALONIKI & DEMOCRITUS UNIVERSITY OF THRACE SCHOOL OF MEDICINE
AOFN SIGNS - ikee.lib.auth.gr
First, I would like to deeply thank Prof. Nikolaos Grigoriadis, Professor of Neurology at the
Aristotle University of Thessaloniki and Head of the Second Department of Neurology, for …
Aristotle University of Thessaloniki and Head of the Second Department of Neurology, for …